Autoinjectors Market Set to Surpass USD 3.02 Billion by 2030 as Demand for Advanced Drug Delivery Systems Accelerates | MarketsandMarkets™.

Delray Beach, FL, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The global autoinjectors market, valued at US$1.08 billion in 2023, stood at US$1.40 billion in 2024 and is projected to advance at a resilient CAGR of 13.6% from 2024 to 2030, culminating in a forecasted valuation of US$3.02 billion by the end of the period. The autoinjector finished formulations market is estimated to reach USD 134.27 billion in 2030 from USD 67.30 billion in 2024, growing at a CAGR of 12.2%.

What is driving this surge? Technological advancements in device design, integration of connectivity features, and rising incidence of severe allergies and chronic diseases are reshaping drug delivery. Regulatory approvals for biologics such as Humira and emerging categories like GLP-1 receptor agonists are further catalyzing adoption.

Why does this matter now? As healthcare systems worldwide emphasize patient-centric care and at-home treatment, autoinjectors are becoming indispensable for self-administration, improving compliance, and reducing hospital dependency.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173991724

Key Growth Drivers

Ease of Use & Accessibility – Simplified administration encourages wider adoption among patients and healthcare providers.
Biologics & Biosimilars Pipeline – Approvals and launches are expanding therapeutic applications.
Smart Technology Integration – Features such as Bluetooth connectivity, dose monitoring, and adherence tracking are redefining patient engagement.

Technology & Usage Trends
How is the technology evolving? The market is segmented into manual and automatic autoinjectors. Manual devices, valued for cost-effectiveness and user control, are projected to record the highest CAGR. Automatic models are also gaining traction with support from regulatory bodies and new product introductions.

In terms of usage, disposable autoinjectors lead due to convenience and hygiene advantages, while reusable models are seeing rising demand, fueled by digital health integrations. Notably, Jabil Healthcare’s Qfinity platform, launched in May 2022, underscores innovation in reusable systems.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=173991724

Route of Administration & Therapy Area Insights
Subcutaneous (SC) administration dominates due to broad formulation availability, ease of use, and minimal training needs. In therapy areas, obesity management is emerging as a high-growth segment, supported by FDA-approved treatments such as Wegovy from Novo Nordisk A/S, recently extended for cardiovascular risk reduction.

Regional Market Dynamics

North America – Maintains market leadership with strong industry presence, favorable reimbursement frameworks, and high chronic disease prevalence.
Asia Pacific – Expected to post significant growth, benefiting from regulatory support and expanding healthcare investment.

Who is Leading the Market?
Prominent players in the autoinjectors space include:

Becton, Dickinson and Company (US) – Expanding into emerging markets through innovation and partnerships.
Ypsomed Holding AG (Switzerland) – Known for geographic expansion and patient-focused solutions, with recent long-term supply agreements with Novo Nordisk.
SHL Medical AG (Switzerland) – Market leader with diverse volume capabilities and plans to scale production.
West Pharmaceutical Services, Inc. (US) and Recipharm AB (Sweden) – Innovating in drug delivery solutions.

In finished formulations, leaders such as AbbVie Inc., Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Johnson & Johnson, Sanofi, and GSK plc hold substantial market influence.

Market Implications for Industry Leaders
How can stakeholders capitalize? Opportunities lie in launching next-generation autoinjectors with integrated smart technology, expanding into high-growth regions, and addressing niche therapeutic needs. With patient preferences shifting towards connected, self-administered therapies, the competitive advantage will favor companies that combine device innovation with data-driven patient engagement strategies.

For more information, Inquire Now

Discover Connected Healthcare Market Opportunities:

Insulin Delivery Devices Market
Pen Needles Market
Wearable Injectors Market
Injection Pen Market
Injectable Drug Delivery Market

Get access to the latest updates on Autoinjectors Companies and Autoinjectors Market Size

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:

Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445,
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: www.marketsandmarkets.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.